Quoted from http://www.cbc.ca/news/health/story/2011/12/22/daibetes-actos-class-action.html
Diabetes drug class action launches
Suit alleges manufacturer should have disclosed increased bladder cancer risk
CBC News
Posted: Dec 22, 2011 11:44 AM ET
DOCUMENT | FDA - Actos (pioglitazone): Ongoing Safety Review
A class action has been launched on behalf of people who took the diabetes drug Actos against the manufacturers of the medication.
The class action alleges that Takeda Pharmaceutical Company, the manufacturer and distributor of Actos (pioglitazone hydrochloride) and Eli Lilly, who used to sell and distribute the drug, failed to disclose that taking it for longer than one year led to an increased risk of bladder cancer.
The suit has been filed with the Ontario Superior Court of Justice.
The lead plaintiff in the class action is a now-deceased Toronto woman who was prescribed Actos in 2002. She died in April after battling bladder cancer for over two years.